Cosmetic cross-reference Noindex: medium evidence

Hematin

CAS 15489-90-4

Hematin (CAS 15489-90-4) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE DrugCentral 055904D152D6

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Hematin

CAS Number

15489-90-4

UNII

0WP180G15G

InChIKey

BMUDPLZKKRQECS-HXFTUNQESA-K

ChEMBL ID

CHEMBL3707238

DrugCentral Struct ID

4565

Source Match

DrugCentral (CAS), FDA GSRS (UNII)

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Hematin used for in pharmaceutical contexts?

Hematin (CAS 15489-90-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Hematin?

No adverse-event association or SIDER side-effect rows are rendered for Hematin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Hematin also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Hematin with EU status "permitted".

What clinical phase is Hematin in?

No phase 1-4 clinical development badge is rendered for Hematin because the matched compound identifier rows do not contain a max-phase value.